Self-Sealing Plugs For Arterial Blood Collection Market Global Report 2026

The self-sealing plugs for arterial blood collection market size has grown strongly in recent years. It will grow from $0.13 billion in 2025 to $0.14 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to growing prevalence of critical care admissions, increasing arterial blood gas testing procedures, rising emphasis on healthcare worker safety, expansion of hospital diagnostic infrastructure, increasing adoption of disposable medical devices.

The self-sealing plugs for arterial blood collection market size is expected to see strong growth in the next few years. It will grow to $0.18 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to growing demand for advanced blood collection safety devices, increasing investments in critical care diagnostics, rising adoption of infection prevention technologies, expanding emergency and intensive care services, strengthening regulatory standards for blood collection systems. Major trends in the forecast period include increasing adoption of closed blood collection systems, rising demand for needle free blood sampling components, growing focus on blood sample integrity and sterility, expansion of leak proof blood collection devices, increasing use of advanced medical grade elastomer components.

The increasing prevalence of chronic respiratory diseases is expected to propel the growth of the self-sealing plugs for arterial blood collection market going forward. Chronic respiratory diseases (CRDs) are long-term lung and airway conditions that cause persistent breathing difficulties, including asthma, chronic obstructive pulmonary disease (COPD), and other chronic pulmonary disorders. The growing prevalence of chronic respiratory diseases is driven by increasing exposure to risk factors such as air pollution and tobacco consumption, which contribute to lung damage, worsen respiratory complications, and increase the demand for respiratory care and treatment solutions. Self-sealing plugs for arterial blood collection support the management of chronic respiratory diseases by enabling safe and efficient arterial blood gas (ABG) sampling, allowing healthcare professionals to accurately monitor oxygen and carbon dioxide levels and evaluate respiratory function in patients with conditions such as asthma and chronic obstructive pulmonary disease (COPD). For instance, in February 2026, according to the Australian Institute of Health and Welfare, an Australia-based government department, asthma contributed to 2.5% of Australia's total disease burden in 2024, was the leading cause of disease burden among children aged 1-9 years, resulted in approximately $1.3 billion in healthcare expenditure during 2023-24, and children and young people aged 0-14 years accounted for 43% of asthma-related hospitalizations. Therefore, the increasing prevalence of chronic respiratory diseases is driving the growth of the self-sealing plugs for arterial blood collection market.

The increasing adoption of arterial blood gas testing in critical care is expected to propel the growth of the self-sealing plugs for arterial blood collection market going forward. Arterial blood gas (ABG) testing in critical care refers to a diagnostic procedure that measures blood oxygen, carbon dioxide, and acid-base balance to support the management of critically ill patients. The increasing adoption of arterial blood gas testing in critical care is driven by the need for continuous patient monitoring, as ABG analysis provides rapid evaluation of oxygen levels, carbon dioxide levels, and acid-base balance to support timely clinical decisions. Self-sealing plugs for arterial blood collection facilitate arterial blood gas testing in critical care by maintaining a closed and sterile blood sampling pathway, minimizing contamination risks, preventing blood leakage, and preserving sample integrity for accurate patient monitoring. For instance, in November 2024, according to the American Association for Respiratory Care (AARC), a US-based non-profit professional association, 95.9% of acute care hospitals reported offering arterial blood gas (ABG) sampling, while 63.9% provided arterial blood gas analysis services. Therefore, the increasing use of arterial blood gas testing in critical care is driving the growth of the self-sealing plugs for arterial blood collection market.

The growing emphasis on healthcare-associated infection prevention is expected to propel the growth of the self-sealing plugs for arterial blood collection market going forward. Healthcare-associated infection (HAI) prevention refers to the strategies and practices implemented in healthcare environments to minimize the risk of infections acquired by patients during medical treatment or procedures. The growing emphasis on healthcare-associated infection prevention is driven by the need to reduce infection risks in healthcare settings, as enhanced infection control practices help prevent pathogen transmission, improve patient safety, and lower healthcare-related complications. Self-sealing plugs for arterial blood collection contribute to healthcare-associated infection prevention by establishing a closed and secure barrier after blood sampling, reducing the risk of blood exposure, contamination, and pathogen transmission during handling and disposal. For instance, in June 2026, according to the Australian Institute of Health and Welfare, an Australia-based government department, hospital-acquired complications were reported in 220,000 out of 12.8 million hospitalizations, with rates of 2.2 per 100 hospitalizations in public hospitals and 0.9 per 100 hospitalizations in private hospitals. Therefore, the growing emphasis on healthcare-associated infection prevention is driving the growth of the self-sealing plugs for arterial blood collection market.

Major companies operating in the self-sealing plugs for arterial blood collection market report are Becton Dickinson and Company, Fresenius Kabi AG, Medtronic plc, B. Braun Melsungen AG, Shandong Weigao Group Medical Polymer Company Limited, Terumo Corporation, ICU Medical Inc., Nipro Corporation, Werfen S.A., Sarstedt AG & Co. KG, Greiner Bio-One International GmbH, Radiometer Medical ApS, Vygon SA, Poly Medicure Limited, Jiangsu Yuyue Medical Equipment & Supply Co. Ltd., JMS Co. Ltd., Sekisui Medical Co. Ltd., Gongdong Medical Technology Co. Ltd., Hindustan Syringes & Medical Devices Limited, Angiplast Private Limited, AdvaCare Pharma, SB-Kawasumi Laboratories Inc., FL Medical S.r.l., Disera Tıbbi Malzeme Lojistik Sanayi ve Ticaret Anonim Şirketi.

North America was the dominant region in the self-sealing plugs for arterial blood collection market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the self-sealing plugs for arterial blood collection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the self-sealing plugs for arterial blood collection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.